Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Live Attenuated Vaccine for Pig market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Bacterial Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Live Attenuated Vaccine for Pig include Merck, Pfizer, GlaxoSmithKline, Astellas Pharma, Johnson & Johnson, CSL, KM Biologics and MSD Animal Health, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Live Attenuated Vaccine for Pig is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable. Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus.
This report aims to provide a comprehensive presentation of the global market for Live Attenuated Vaccine for Pig, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Attenuated Vaccine for Pig. This report contains market size and forecasts of Live Attenuated Vaccine for Pig in global, including the following market information:
Global Live Attenuated Vaccine for Pig Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Live Attenuated Vaccine for Pig Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Live Attenuated Vaccine for Pig companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Live Attenuated Vaccine for Pig manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Live Attenuated Vaccine for Pig Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Live Attenuated Vaccine for Pig Market Segment Percentages, by Type, 2022 (%)
Bacterial Vaccines
Viral Vaccines
Global Live Attenuated Vaccine for Pig Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Live Attenuated Vaccine for Pig Market Segment Percentages, by Application, 2022 (%)
Piglet
Adult Pig
Global Live Attenuated Vaccine for Pig Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Live Attenuated Vaccine for Pig Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Live Attenuated Vaccine for Pig revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Live Attenuated Vaccine for Pig revenues share in global market, 2022 (%)
Key companies Live Attenuated Vaccine for Pig sales in global market, 2018-2023 (Estimated), (Units)
Key companies Live Attenuated Vaccine for Pig sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Pfizer
GlaxoSmithKline
Astellas Pharma
Johnson & Johnson
CSL
KM Biologics
MSD Animal Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of Live Attenuated Vaccine for Pig, market overview.
Chapter 2: Global Live Attenuated Vaccine for Pig market size in revenue and volume.
Chapter 3: Detailed analysis of Live Attenuated Vaccine for Pig manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Live Attenuated Vaccine for Pig in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Live Attenuated Vaccine for Pig capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Live Attenuated Vaccine for Pig Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Live Attenuated Vaccine for Pig Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Live Attenuated Vaccine for Pig Overall Market Size
2.1 Global Live Attenuated Vaccine for Pig Market Size: 2022 VS 2029
2.2 Global Live Attenuated Vaccine for Pig Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Live Attenuated Vaccine for Pig Sales: 2018-2029
3 Company Landscape
3.1 Top Live Attenuated Vaccine for Pig Players in Global Market
3.2 Top Global Live Attenuated Vaccine for Pig Companies Ranked by Revenue
3.3 Global Live Attenuated Vaccine for Pig Revenue by Companies
3.4 Global Live Attenuated Vaccine for Pig Sales by Companies
3.5 Global Live Attenuated Vaccine for Pig Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Live Attenuated Vaccine for Pig Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Live Attenuated Vaccine for Pig Product Type
3.8 Tier 1, Tier 2 and Tier 3 Live Attenuated Vaccine for Pig Players in Global Market
3.8.1 List of Global Tier 1 Live Attenuated Vaccine for Pig Companies
3.8.2 List of Global Tier 2 and Tier 3 Live Attenuated Vaccine for Pig Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Live Attenuated Vaccine for Pig Market Size Markets, 2022 & 2029
4.1.2 Bacterial Vaccines
4.1.3 Viral Vaccines
4.2 By Type - Global Live Attenuated Vaccine for Pig Revenue & Forecasts
4.2.1 By Type - Global Live Attenuated Vaccine for Pig Revenue, 2018-2023
4.2.2 By Type - Global Live Attenuated Vaccine for Pig Revenue, 2024-2029
4.2.3 By Type - Global Live Attenuated Vaccine for Pig Revenue Market Share, 2018-2029
4.3 By Type - Global Live Attenuated Vaccine for Pig Sales & Forecasts
4.3.1 By Type - Global Live Attenuated Vaccine for Pig Sales, 2018-2023
4.3.2 By Type - Global Live Attenuated Vaccine for Pig Sales, 2024-2029
4.3.3 By Type - Global Live Attenuated Vaccine for Pig Sales Market Share, 2018-2029
4.4 By Type - Global Live Attenuated Vaccine for Pig Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Live Attenuated Vaccine for Pig Market Size, 2022 & 2029
5.1.2 Piglet
5.1.3 Adult Pig
5.2 By Application - Global Live Attenuated Vaccine for Pig Revenue & Forecasts
5.2.1 By Application - Global Live Attenuated Vaccine for Pig Revenue, 2018-2023
5.2.2 By Application - Global Live Attenuated Vaccine for Pig Revenue, 2024-2029
5.2.3 By Application - Global Live Attenuated Vaccine for Pig Revenue Market Share, 2018-2029
5.3 By Application - Global Live Attenuated Vaccine for Pig Sales & Forecasts
5.3.1 By Application - Global Live Attenuated Vaccine for Pig Sales, 2018-2023
5.3.2 By Application - Global Live Attenuated Vaccine for Pig Sales, 2024-2029
5.3.3 By Application - Global Live Attenuated Vaccine for Pig Sales Market Share, 2018-2029
5.4 By Application - Global Live Attenuated Vaccine for Pig Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Live Attenuated Vaccine for Pig Market Size, 2022 & 2029
6.2 By Region - Global Live Attenuated Vaccine for Pig Revenue & Forecasts
6.2.1 By Region - Global Live Attenuated Vaccine for Pig Revenue, 2018-2023
6.2.2 By Region - Global Live Attenuated Vaccine for Pig Revenue, 2024-2029
6.2.3 By Region - Global Live Attenuated Vaccine for Pig Revenue Market Share, 2018-2029
6.3 By Region - Global Live Attenuated Vaccine for Pig Sales & Forecasts
6.3.1 By Region - Global Live Attenuated Vaccine for Pig Sales, 2018-2023
6.3.2 By Region - Global Live Attenuated Vaccine for Pig Sales, 2024-2029
6.3.3 By Region - Global Live Attenuated Vaccine for Pig Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Live Attenuated Vaccine for Pig Revenue, 2018-2029
6.4.2 By Country - North America Live Attenuated Vaccine for Pig Sales, 2018-2029
6.4.3 US Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.4.4 Canada Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.4.5 Mexico Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Live Attenuated Vaccine for Pig Revenue, 2018-2029
6.5.2 By Country - Europe Live Attenuated Vaccine for Pig Sales, 2018-2029
6.5.3 Germany Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.5.4 France Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.5.5 U.K. Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.5.6 Italy Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.5.7 Russia Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.5.8 Nordic Countries Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.5.9 Benelux Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Live Attenuated Vaccine for Pig Revenue, 2018-2029
6.6.2 By Region - Asia Live Attenuated Vaccine for Pig Sales, 2018-2029
6.6.3 China Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.6.4 Japan Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.6.5 South Korea Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.6.6 Southeast Asia Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.6.7 India Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Live Attenuated Vaccine for Pig Revenue, 2018-2029
6.7.2 By Country - South America Live Attenuated Vaccine for Pig Sales, 2018-2029
6.7.3 Brazil Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.7.4 Argentina Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Live Attenuated Vaccine for Pig Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Live Attenuated Vaccine for Pig Sales, 2018-2029
6.8.3 Turkey Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.8.4 Israel Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.8.5 Saudi Arabia Live Attenuated Vaccine for Pig Market Size, 2018-2029
6.8.6 UAE Live Attenuated Vaccine for Pig Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Live Attenuated Vaccine for Pig Major Product Offerings
7.1.4 Merck Live Attenuated Vaccine for Pig Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Live Attenuated Vaccine for Pig Major Product Offerings
7.2.4 Pfizer Live Attenuated Vaccine for Pig Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Live Attenuated Vaccine for Pig Major Product Offerings
7.3.4 GlaxoSmithKline Live Attenuated Vaccine for Pig Sales and Revenue in Global (2018-2023)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 Astellas Pharma
7.4.1 Astellas Pharma Company Summary
7.4.2 Astellas Pharma Business Overview
7.4.3 Astellas Pharma Live Attenuated Vaccine for Pig Major Product Offerings
7.4.4 Astellas Pharma Live Attenuated Vaccine for Pig Sales and Revenue in Global (2018-2023)
7.4.5 Astellas Pharma Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Live Attenuated Vaccine for Pig Major Product Offerings
7.5.4 Johnson & Johnson Live Attenuated Vaccine for Pig Sales and Revenue in Global (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 CSL
7.6.1 CSL Company Summary
7.6.2 CSL Business Overview
7.6.3 CSL Live Attenuated Vaccine for Pig Major Product Offerings
7.6.4 CSL Live Attenuated Vaccine for Pig Sales and Revenue in Global (2018-2023)
7.6.5 CSL Key News & Latest Developments
7.7 KM Biologics
7.7.1 KM Biologics Company Summary
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Live Attenuated Vaccine for Pig Major Product Offerings
7.7.4 KM Biologics Live Attenuated Vaccine for Pig Sales and Revenue in Global (2018-2023)
7.7.5 KM Biologics Key News & Latest Developments
7.8 MSD Animal Health
7.8.1 MSD Animal Health Company Summary
7.8.2 MSD Animal Health Business Overview
7.8.3 MSD Animal Health Live Attenuated Vaccine for Pig Major Product Offerings
7.8.4 MSD Animal Health Live Attenuated Vaccine for Pig Sales and Revenue in Global (2018-2023)
7.8.5 MSD Animal Health Key News & Latest Developments
8 Global Live Attenuated Vaccine for Pig Production Capacity, Analysis
8.1 Global Live Attenuated Vaccine for Pig Production Capacity, 2018-2029
8.2 Live Attenuated Vaccine for Pig Production Capacity of Key Manufacturers in Global Market
8.3 Global Live Attenuated Vaccine for Pig Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Live Attenuated Vaccine for Pig Supply Chain Analysis
10.1 Live Attenuated Vaccine for Pig Industry Value Chain
10.2 Live Attenuated Vaccine for Pig Upstream Market
10.3 Live Attenuated Vaccine for Pig Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Live Attenuated Vaccine for Pig Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
